Mark Cobbold
About
Mark Cobbold is a scholar working on Immunology, Oncology and Epidemiology.
According to data from OpenAlex, Mark Cobbold has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 20 papers in Oncology and 16 papers in Epidemiology. Recurrent topics in Mark Cobbold's work include Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (13 papers) and Cytomegalovirus and herpesvirus research (13 papers). Mark Cobbold is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (13 papers) and Cytomegalovirus and herpesvirus research (13 papers). Mark Cobbold collaborates with scholars based in United Kingdom, United States and Germany. Mark Cobbold's co-authors include Paul Moss, Naeem Khan, Laxman Nayak, Rachel Bruton, Alan J. Sinclair, Charles Craddock, John M. Goldman, Russell Keenan, Alan B. Rickinson and Andrew D. Hislop and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.
In The Last Decade
Mark Cobbold
54 papers receiving 2.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Cobbold United Kingdom | 22 | 1.6k | 1.4k | 807 | 535 | 243 | 58 | 2.9k | ||
| Dieter Kube Germany | 30 | 1.4k 0.9× | 764 0.5× | 1.1k 1.4× | 794 1.5× | 191 0.8× | 76 | 3.2k | ||
| Julie Déchanet‐Merville France | 31 | 3.1k 2.0× | 966 0.7× | 1.0k 1.3× | 584 1.1× | 173 0.7× | 74 | 4.3k | ||
| Afsar Rahbar Sweden | 30 | 867 0.6× | 1.8k 1.3× | 649 0.8× | 437 0.8× | 145 0.6× | 81 | 2.7k | ||
| José Torrealba United States | 33 | 1.4k 0.9× | 506 0.4× | 460 0.6× | 682 1.3× | 241 1.0× | 111 | 4.2k | ||
| David G. Bowen Australia | 29 | 1.7k 1.1× | 1.3k 0.9× | 345 0.4× | 483 0.9× | 318 1.3× | 85 | 3.7k | ||
| Klaas P. J. M. van Gisbergen Netherlands | 32 | 2.8k 1.8× | 372 0.3× | 772 1.0× | 655 1.2× | 179 0.7× | 63 | 3.5k | ||
| Hiroyuki Nakamura Japan | 26 | 563 0.4× | 857 0.6× | 1.0k 1.3× | 297 0.6× | 119 0.5× | 67 | 2.0k | ||
| Florian Weisel United States | 21 | 2.1k 1.4× | 456 0.3× | 246 0.3× | 630 1.2× | 159 0.7× | 27 | 3.0k | ||
| John R. Šedý United States | 21 | 2.8k 1.8× | 536 0.4× | 1.1k 1.4× | 532 1.0× | 232 1.0× | 28 | 3.6k | ||
| Yoshinobu Koguchi United States | 31 | 1.7k 1.1× | 729 0.5× | 752 0.9× | 401 0.7× | 64 0.3× | 67 | 2.8k |
Countries citing papers authored by Mark Cobbold
Since
Specialization
Citations
This map shows the geographic impact of Mark Cobbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cobbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cobbold more than expected).
Fields of papers citing papers by Mark Cobbold
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mark Cobbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cobbold. The network helps show where Mark Cobbold may publish in the future.
Co-authorship network of co-authors of Mark Cobbold
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Cobbold. A scholar is included among the top collaborators of Mark Cobbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Cobbold. Mark Cobbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Breen, Shannon, Rosa A. Carrasco, Kelly McGlinchey, et al.. (2024). Abstract 1435: Utilization of CLDN18.2 syngeneic mouse models to study chimeric antigen receptor T cells in immunocompetent mice. Cancer Research. 84(6_Supplement). 1435–1435.
2.
Lawrence, R. F., Corinne Cayatte, M. Fernández, et al.. (2024). Pre-Clinical Evaluation of AZD5492, a Novel CD8-Guided T Cell Engager, for B-Non Hodgkin Lymphoma Indications. Blood. 144(Supplement 1). 959–959.
3.
Heather, James, Matthew Spindler, David G. Millar, et al.. (2022). Stitchr: stitching coding TCR nucleotide sequences from V/J/CDR3 information. Nucleic Acids Research. 50(12). e68–e68.
4.
Malhotra, Deepali, Eleanor Clancy‐Thompson, Bilal Omar, et al.. (2022). 469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT. Regular and Young Investigator Award Abstracts. A489–A489.
5.
Spindler, Matthew, John S. Bridgeman, James Heather, et al.. (2020). Massively parallel interrogation and mining of natively paired human TCRαβ repertoires. Nature Biotechnology. 38(5). 609–619.
6.
Barmettler, Sara, Mei‐Sing Ong, Jocelyn R. Farmer, et al.. (2019). Gastrointestinal manifestations in common variable immunodeficiency (CVID) are associated with an altered immunophenotype including B- and T-cell dysregulation. The Journal of Allergy and Clinical Immunology In Practice. 8(4). 1436–1438.e1.
7.
Malaker, Stacy A., Sarah Penny, Justin Loke, et al.. (2017). Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia. Cancer Immunology Research. 5(5). 376–384.
8.
Wong, Gabriel K.Y., James Heather, Sara Barmettler, & Mark Cobbold. (2017). Immune dysregulation in immunodeficiency disorders: The role of T-cell receptor sequencing. Journal of Autoimmunity. 80. 1–9.
9.
Nath, Jay, Thomas B. Smith, Mark Cobbold, et al.. (2014). Metabolomic Perfusate Analysis during Kidney Machine Perfusion: The Pig Provides an Appropriate Model for Human Studies. PLoS ONE. 9(12). e114818–e114818.
10.
Campbell, John P., Jennifer Heaney, Mark Cobbold, et al.. (2013). Validation of a rapid lateral-flow test for the diagnosis and monitoring of immunoglobulin free light chains: Retrospective analysis of sera from patients with plasma cell dyscrasias. Clinical Chemistry. 59(10).
11.
Micoli, Francesca, Massimiliano Gavini, Margaret Goodall, et al.. (2012). Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography. Journal of Immunological Methods. 387(1-2). 199–210.
12.
Birtwistle, Jane, Alex Richter, John P. Campbell, et al.. (2012). Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay. Journal of Immunological Methods. 377(1-2). 37–46.
13.
Khan, Naeem, Mark Cobbold, Joanne A. Cummerson, & Paul Moss. (2010). Persistent viral infection in humans can drive high frequency low‐affinity T‐cell expansions. Immunology. 131(4). 537–548.
14.
Chakupurakal, Geothy, David Onion, Mark Cobbold, Vivien Mautner, & Paul Moss. (2009). Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin α4β7. AIDS. 24(2). 205–210.
15.
Mohammed, Fiyaz, Mark Cobbold, Angela L. Zarling, et al.. (2008). Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nature Immunology. 9(11). 1236–1243.
16.
Jones, Matthew A., et al.. (2007). Synthesis and ex vivo profiling of chemically modified cytomegalovirus CMVpp65 epitopes. Journal of Peptide Science. 14(3). 313–320.
17.
Das, Sayantan, Maryam Shahmanesh, Michael Stolinski, et al.. (2006). In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100. Diabetologia. 49(3). 538–542.
18.
Khan, Naeem, Andrew D. Hislop, Nancy Gudgeon, et al.. (2004). Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection. The Journal of Immunology. 173(12). 7481–7489.
19.
Khan, Naeem, Mark Cobbold, Russell Keenan, & Paul Moss. (2002). Comparative Analysis of CD8+T Cell Responses against Human Cytomegalovirus Proteins pp65 and Immediate Early 1 Shows Similarities in Precursor Frequency, Oligoclonality, and Phenotype. The Journal of Infectious Diseases. 185(8). 1025–1034.
20.
Keenan, Russell, Naeem Khan, Rachel Bruton, et al.. (2001). Purification of cytomegalovirus‐specific CD8 T cells from peripheral blood using HLA–peptide tetramers. British Journal of Haematology. 115(2). 428–434.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dieter Kube Breakdown of academic impact, for papers by Julie Déchanet‐Merville Breakdown of academic impact, for papers by Afsar Rahbar Breakdown of academic impact, for papers by José Torrealba Breakdown of academic impact, for papers by David G. Bowen Breakdown of academic impact, for papers by Klaas P. J. M. van Gisbergen Breakdown of academic impact, for papers by Hiroyuki Nakamura Breakdown of academic impact, for papers by Florian Weisel Breakdown of academic impact, for papers by John R. Šedý Breakdown of academic impact, for papers by Yoshinobu Koguchi